中健康桥IPO：董事长刘宗杰夫妇控股95%，妻子章芳芳出任董事

Core Viewpoint - Zhong Health Bridge Pharmaceutical Group Co., Ltd. has received approval for its IPO on the Beijing Stock Exchange, aiming to raise 559 million yuan for various projects including the expansion of its powder injection production line and innovative drug research [1][2]. Group 1: Company Overview - Zhong Health Bridge focuses on chronic diseases, particularly cardiovascular medications, and operates a modern pharmaceutical enterprise with its R&D headquarters in Guangzhou [1]. - The company has established a modern manufacturing base in Linyi, with an annual production capacity of 400 million tablets, 400 million capsules, 400 tons of granules, 300 tons of powders, 300 tons of water pills, 150 tons of tea medicines, and 72 million oral liquids [1]. Group 2: Financial Performance - Projected revenues for Zhong Health Bridge from 2022 to 2024 are 268 million yuan, 344 million yuan, and 447 million yuan, respectively, with net profits of 61.09 million yuan, 111 million yuan, and 103 million yuan [2]. - The comprehensive gross profit margins for the same period are 91.71%, 93.20%, and 92.66% [2]. Group 3: Fundraising and Investment Projects - The total investment for the projects funded by the IPO is approximately 55.92 million yuan, which includes: - 17.39 million yuan for the expansion of the powder injection production line - 30 million yuan for innovative drug research - 3.52 million yuan for information system upgrades - 5 million yuan for working capital [2]. Group 4: Shareholder Structure - Liu Zongjie directly holds 13.44 million shares (17.82% of total shares), while Zhang Fangfang holds 3.72 million shares (4.93%) [3]. - Liu Zongjie and Zhang Fangfang control a total of 57.58% of the company through their entity Furong Kangda, along with other entities, resulting in a combined control of 95.49% [5]. Group 5: Management Background - Liu Zongjie, born in November 1977, has extensive experience in the pharmaceutical industry, having held various leadership roles since 2000 [7]. - Zhang Fangfang, born in April 1984, has also held significant positions within the industry, contributing to the company's management since 2011 [7].